US Stock MarketDetailed Quotes

TSHA Taysha Gene Therapies

Watchlist

1.7300
+0.0100+0.58%

Close Mar 11 16:00 ET

1.6614
-0.0686-3.97%

Post 16:20 ET

354.65MMarket Cap-4.81P/E (TTM)

Taysha Gene Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Taysha Gene Therapies Q4 2024 Earnings Date

Currency：USDFeb 26, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	2.05M	2.02M	-30.91K
Miss Est.	-43.04%	-43.90%	-1.51%
EPS	-0.08	-0.07	+0.01
Beat Est.	-108.98%	-127.41%	+15.25%

Analyst Rating

Strong Buy

Mar 1, 2025

Taysha Gene Therapies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 1.767M	--
--	2025/Q1	-- / 1.482M	--
Feb 26, 2025	2024/Q4	2.022M / 2.053M	--
Nov 13, 2024	2024/Q3	1.788M / 1.649M	--
Aug 12, 2024	2024/Q2	1.112M / 2.632M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 1.767M--

--2025/Q1-- / 1.482M--

Feb 26, 20252024/Q42.022M / 2.053M--

Nov 13, 20242024/Q31.788M / 1.649M--

Aug 12, 20242024/Q21.112M / 2.632M--

Unlock Free Earnings Estimates

Open Account

Taysha Gene Therapies Earnings Reports

Taysha Gene Therapies | 10-K: FY2024 Annual Report

Feb 26 08:46 ET

Taysha Gene Therapies | 10-Q: Q3 2024 Earnings Report

Nov 13, 2024 16:44 ET

Taysha Gene Therapies | 8-K: Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 13, 2024 16:17 ET

Taysha Gene Therapies | 10-Q: Q2 2024 Earnings Report

Aug 12, 2024 08:36 ET